Key Takeaways
- Soft quarter, margin resilience: Revenue fell 3.8% YoY as US tariff uncertainty and India's GST transition hit volumes, yet normalized EBITDA margin expanded 200 bps QoQ to 12.1% through product mix improvement and cost discipline.
- Three large projects near the finish line: Egypt aseptic packaging, India recycling, and Mexico WPP plants are all expected to commission within 90 days, setting the stage for a step-up in revenue and EBITDA from Q1 FY27.
- Packaging films hit by trade diversion, not demand destruction: Exports originally destined for the US flooded Europe and MENA, creating a supply glut and pricing pressure. Management sees this reversing as tariff uncertainty eases and supply chains normalize.
- Aseptic packaging is the bright spot: Volumes grew 2.3% YoY in Q3 and management expects ~850 crore packs for FY26, with Q4 and Q1 seasonally the strongest quarters and category tailwinds intact.
- What to watch next quarter: Whether the three projects commission on time, the pace of packaging film price recovery, and any firm FY27 aseptic volume guidance once the Egypt plant is running.
Packaging Films: The Trade-Diversion Shock
- What hurt Q3: US tariff-related uncertainty prompted a reorientation of exports away from the US market. The extra supply of films originally destined for the US flooded Europe, North Africa, and the Middle East, creating a supply-demand mismatch and pricing pressure across those regions.
- Capacity utilization dipped sharply at Mexico, Hungary, and Poland plants because of this diverted supply, plus seasonal factors (Eastern European holidays) and destocking by warehouse and wholesaler players who expected further price declines.
- The reversal is underway: By end-Q3 and into the current quarter, tariff uncertainties are easing as multiple countries make deals with the US. In India, BOPET film prices have recovered by about ₹100/ton, and BOPP films have shown marked improvement. Management expects utilization at Mexico, Hungary, and Poland to return to ~80%+ in the coming fiscal.
- Value-added films as a structural hedge: The company has added capacity for metallized, AlOx, and ultra-high barrier films in Egypt, Hungary, and other locations. These films require less incremental capex proportionally, command better realization, and are forming an increasing share of the overall packaging films segment. In evolved markets, demand for high-barrier, specialized films remains strong.
- Raw material prices stabilizing: RM prices had been weighed down by Chinese imports, but the Chinese government has shifted toward holding price rather than chasing volume, leading to more consistent RM prices.
Sumeet Kumar: "we see in the current quarter that trend in fact is showing some signs of reversal"
Three Projects Near Commissioning
- The projects: (1) 1,200 crore packs expansion of aseptic liquid packaging facilities in Egypt; (2) ~40,000 ton recycling plant in India; (3) 8,000 crore bag production capacity (woven polypropylene) in Mexico. All three are expected to be commissioned between the current quarter and end of Q1 FY27, within roughly 90 days.
- Revenue and margin contribution: On full capacity utilization, the three plants are expected to generate incremental revenue of Rs. 2,000–2,500 crore with high-teens margin. For the next fiscal, at 60–70% utilization, numbers can be calibrated accordingly.
- Egypt PET plant utilization is expected to reach close to 80% in the coming year; Panipat PET plant utilization is expected to improve from 79% to upward of 85–90%. Management noted that crossing 80–90% would mean thinking of a new plant, which is not required at this point.
- Panipat technical upgrade: The plant has technically improved to produce more BG grade chips, which will improve realization and margin profile even at similar utilization levels.
Sumeet Kumar: "I am expecting this between current and next quarter. We are just around the corner about commissioning of that plant. I think it may be somewhere within 90 days from now, so that can be either end of this quarter or somewhere in the first quarter."
Aseptic Packaging: The Growth Engine
- Volume growth: Aseptic packaging volumes grew 2.3% YoY in Q3 and 4.4% in 9M, reflecting strong execution and improved product mix.
- Seasonality tailwind: Q4 and Q1 are seasonally the strongest quarters for aseptic packaging. Management expects much better prospects in the current quarter and next, supported by category tailwinds and pre-season loading, assuming trade inventory liquidation and inclement weather conditions are now largely behind.
- FY26 volume target: Management expects full-year aseptic packaging volumes around ~850 crore packs, subject to overall F&B beverage industry conditions.
- FY27 guidance deferred: Management declined to give a specific volume range for FY27, saying they need to first reach the commissioning stage of the Egypt facility and will be in a better position to give numbers after the current quarter ends.
- Domestic demand story: Management expects exponential growth in the liquid packaging industry segment in India. UFlex is already the market leader and expects to further consolidate that position. The domestic market demand is the reason for strategically investing in Indian capacity expansion.
Sumeet Kumar: "quarter 4 and quarter 1 are seasonally the strongest quarter for aseptic packaging business"
Leverage, Debt & Capex
- Leverage at its peak: Management sees the net debt-to-EBITDA ratio as having peaked at current levels. Improvement will come from EBITDA improvement, not debt reduction in isolation. No specific leverage target or timeline was given.
- Debt repayment and remaining capex: Repayment of Rs. 1,450–1,500 crore and remaining capex of about Rs. 1,200 crore should largely square off. No significant addition in debt is expected, but improvement in the leverage ratio will be based on improved EBITDA, not necessarily a reduced absolute debt number.
- Cost of funds: Management is working on a plan to steadily bring down the cost of funds. The combination of the capex cycle ending, EBITDA improvement, and lower cost of funds will improve the debt profile.
- Debt composition: 60% of overseas debt is in capex investment for major growth plans, aligned with overseas growth plans. Slide 24 of the presentation already provides the long-term vs. working capital split (74%/26%) and domestic vs. overseas split within long-term debt (40%/60%).
Sumeet Kumar: "we see this leverage ratio, which is at the current level, more or less being at the peak"
Margin Trajectory & Outlook
- Q3 margin expansion: Reported EBITDA margin expanded 180 bps QoQ to 12.7%; normalized EBITDA margin expanded 200 bps QoQ to 12.1%, driven by product mix improvement and cost optimization despite a 3.8% YoY revenue decline.
- FY26 EBITDA guidance: Management is confident of achieving Rs. 1,800–1,850 crore EBITDA for FY26, with full-year margin in the range of ~12%.
- FY27 margin outlook: Expect improvement from 12% further upwards due to improved product mix, cost rationalization, and better price realization.
- Q4 expected to be much better: Packaging films: worst challenges behind, prices have firmed up. Flexible packaging: signs of improvement from the successful GST transition, destocking is over. Aseptic: Q4 is typically a better quarter.
- Chemical business stabilizing: The dip in the chemical business this quarter was a combination of product mix change and broader industry trends. This segment is also stabilizing and a better performance is expected.
Sumeet Kumar: "We definitely see that margin, while it has shown on a sequential quarter basis, it has seen an expansion of 200 basis points over the previous quarter, which is currently at for nine months it's about 11.5%. We see it in the range of about 12% or so for the year as a whole."
EPR & Recycling: A Strategic Bet
- EPR implementation delayed: Government guidelines had talked about 30% to 10% or 5% recycling material mix for rigid, flexible, and multi-material flexible plastic. The government has pushed this out; what was expected by this fiscal will now play out in the coming years. A window of the next 3 years is available to make up for what was not implemented now.
- UFlex positioned as early beneficiary: UFlex, being one of the best-entrenched players in recycling capacity, expects to be the early beneficiary and should get the benefit of its significant strategic investment as EPR implementation actually begins.
- The ~40,000 ton recycling plant in India, one of the three projects near commissioning, is the tangible asset behind this strategic positioning.
Sumeet Kumar: "EPR in fact is very close to our heart. It is a very strategic investment from our side, and we feel that this government is also equally committed to this thing, translating into what we believe should be something which should be of excellent prospect for us."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Three projects commissioning | Egypt aseptic, India recycling, Mexico WPP plants operational | Within 90 days (current quarter to end of Q1 FY27) |
| FY26 aseptic packaging volumes | ~850 crore packs | FY26 full year |
| FY26 EBITDA | Rs. 1,800–1,850 crore | FY26 full year |
| FY26 EBITDA margin | ~12% | FY26 full year |
| FY27 EBITDA margin | Improvement upward from 12% | FY27 |
| Capacity utilization (Mexico, Hungary, Poland) | Return to ~80%+ | Coming fiscal |
| Egypt PET plant utilization | Close to 80% | Coming year |
| Panipat PET plant utilization | Upward of 85–90% (from 79%) | Coming year |
| Three new plants incremental revenue | Rs. 2,000–2,500 crore at full utilization; FY27 at 60–70% utilization | Full utilization (undated); FY27 partial |
| Leverage ratio | Peaked at current level; improvement via EBITDA growth | Ongoing |
| Debt repayment | Rs. 1,450–1,500 crore | Next one year |
| Remaining capex | ~Rs. 1,200 crore | Near term |
Key Metrics
| Metric | Q3 FY26 |
|---|---|
| Revenue | ₹3,632.9 cr, down 3.8% YoY from ₹3,777.5 cr |
| Revenue (9M FY26) | ₹11,415.7 cr, up 0.8% YoY |
| Reported EBITDA | ₹459.6 cr, up 9.7% YoY; margin 12.7%, up 180 bps QoQ |
| Normalized EBITDA | ₹439.5 cr, up 12.8% QoQ; margin 12.1%, up 200 bps QoQ (adjusted for ₹20.1 cr forex and derivative gains) |
| Normalized EBITDA (9M FY26) | ~₹1,300 cr, down 9.6% YoY; margin 11.4% |
| Profit before exceptional items | ₹64.3 cr, up 56% QoQ |
| PAT | ₹36.1 cr, up 34% QoQ |
| PAT (9M FY26) | ₹121 cr vs loss of ₹26.3 cr in 9M last year |
| EPS | ₹5.01 per share |
| Aseptic packaging volumes | 180 cr packs, up 2.3% YoY from 176 cr packs |
| Aseptic packaging volumes (9M FY26) | 590 cr packs, up 4.4% YoY from 570 cr packs |
| Aseptic packaging full-year FY26 target | ~850 cr packs |
| Revenue mix | 44% India, 56% overseas |
| BOPET film price (India, current) | ~₹110 per kg, recovered from ~₹90 per kg low |
| BOPP NTT grade price (current) | ₹120–₹121 per kg, improved significantly from previous month |
| Egypt PET plant capacity utilization (Q3) | 45%–46%; 9M: 57.8% |
| Panipat PET chips plant capacity utilization (9M) | ~79% |
| Poland capacity utilization (Q3) | 56.7% |
| Blended cost of funds | 6.9%–7% |
| Current maturities (next 12 months) | ₹1,450 cr–₹1,500 cr |
| Remaining capex | ~₹1,200 cr (Egypt aseptic: ~₹350 cr, Noida recycling: ~₹110–₹120 cr, BOPP Dharwad: balance) |
| Long-term debt as % of total debt | 74%; working capital and short-term: 26% |
| Domestic vs overseas long-term debt split | 40% domestic, ~60% overseas |
| FY26 EBITDA guidance | ₹1,800 cr–₹1,850 cr, margin ~12% |
| Incremental revenue from three new plants (full utilization) | ₹2,000 cr–₹2,500 cr, margin high-teens |